Calumet Specialty Products (CLMT): The Perfect Mix of Value and Rising Earnings Estimates? - Tale of the Tape

Shutterstock photo

Value investing is always a very popular strategy, and for good reason. After all, who doesn't want to find stocks that have low PEs, solid outlooks, and decent dividends?

Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; Calumet Specialty Products Partners LP ( CLMT ).

Calumet Specialty Products in Focus

CLMT may be an interesting play thanks to its forward PE of 19.63, its P/S ratio of 0.36, and its decent dividend yield of 9.74%. These factors suggest that Calumet Specialty Products is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that CLMT has decent revenue metrics to back up its earnings.

But before you think that Calumet Specialty Products is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has gone up by 2.9% in the past 30 days, thanks to 2 upward revisions in the past one month compared to none lower.

The company currently holds a Zacks Rank #3 (Hold), which is also a favorable signal. So really, Calumet Specialty Products is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

CALUMET SPECLTY (CLMT): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Earnings , Investing Ideas , Stocks
Referenced Symbols: CLMT

More from Zacks.com




Equity Research

Research Brokers before you trade

Want to trade FX?